Answers are grounded in this paper and cite their sources.
This review discusses the role of PP2A in disease and its potential therapeutic targeting in conditions like cancer and Alzheimer's.
Protein phosphatases of the type 2A family (PP2A) represent a major fraction of cellular Ser/Thr phosphatase activity in any given human tissue. In this review, we describe how the holoenzymic nature of PP2A and the existence of several distinct PP2A composing subunits allow for the generation of multiple structurally and functionally different PP2A complexes, explaining why PP2A is involved in the regulation of so many diverse cell biological and physiological processes. Moreover, in human disease, most notably in several cancers and Alzheimer's Disease, PP2A expression and/or activity have been found significantly decreased, underscoring its important functions as a major tumor suppressor and tau phosphatase. Hence, several recent preclinical studies have demonstrated that pharmacological restoration of PP2A activity, as well as pharmacological PP2A inhibition, under certain conditions, may be of significant future therapeutic value.
No takes yet. Share an insight, caveat, or question.
Lambrecht et al. (2013) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: